Cargando…

Construction and validation of m(6)A RNA methylation regulators associated prognostic model for gastrointestinal cancer

N6‐methyladenosine (m(6)A) RNA methylation is correlated with carcinogenesis and dynamically possessed through the m(6)A RNA methylation regulators. This paper aimed to explore 13 m(6)A RNA methylation regulators' role in gastrointestinal cancer (GIC) and determine the risk model and prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Yandong, Su, Bin, Tang, Xiaolong, Wang, Jiangtao, Quan, Wuxia, Chen, Yonggang, Mi, Denghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965361/ https://www.ncbi.nlm.nih.gov/pubmed/35174637 http://dx.doi.org/10.1049/syb2.12040

Ejemplares similares

Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer
por: Miao, Yandong, et al.
Publicado: (2021)

Prognostic implications of metabolism-associated gene signatures in colorectal cancer
por: Miao, Yandong, et al.
Publicado: (2020)

Role of gasdermin family proteins in the occurrence and progression of hepatocellular carcinoma
por: Miao, Yandong, et al.
Publicado: (2022)

Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2021)

Single‐cell RNA‐seq and bulk RNA‐seq explore the prognostic value of exhausted T cells in hepatocellular carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Identification prognosis-associated immune genes in colon adenocarcinoma
por: Miao, Yandong, et al.
Publicado: (2020)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Angelica polysaccharides relieve blood glucose levels in diabetic KKAy mice possibly by modulating gut microbiota: an integrated gut microbiota and metabolism analysis
por: Tang, Xiaolong, et al.
Publicado: (2023)

Copper in cancer: from limiting nutrient to therapeutic target
por: Tang, Xiaolong, et al.
Publicado: (2023)

Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer
por: Xu, Li-chao, et al.
Publicado: (2020)

Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis
por: Wu, Tong, et al.
Publicado: (2022)

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2022)

Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation
por: Quan, Yongjun, et al.
Publicado: (2022)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Construction and validation of a prognostic risk model of angiogenesis factors in skin cutaneous melanoma
por: Zou, Songyun, et al.
Publicado: (2022)

Identification and validation of m(6)A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
por: Wang, Xinyi, et al.
Publicado: (2020)

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics
por: Li, Huijun, et al.
Publicado: (2022)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13
por: Wang, Jiangtao, et al.
Publicado: (2021)

Construction and Validation of a m7G-Related Gene-Based Prognostic Model for Gastric Cancer
por: Li, Xin-yu, et al.
Publicado: (2022)

Construction and validation of a prognostic model for gastrointestinal stromal tumors based on copy number alterations and clinicopathological characteristics
por: Zhao, Heng, et al.
Publicado: (2022)

Prognostic value of m6A regulators and the nomogram construction in glioma patients
por: Liu, Pengdi, et al.
Publicado: (2022)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

Prognostic and therapeutic implication of m6A methylation in Crohn disease
por: He, Yujin, et al.
Publicado: (2022)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma
por: Bai, Zhiqun, et al.
Publicado: (2022)

Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer
por: Zhao, Xugui, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Construction of miRNA-mRNA network and a nomogram model of prognostic analysis for prostate cancer
por: Su, Qiang, et al.
Publicado: (2022)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
por: Yang, Jing, et al.
Publicado: (2022)

The prognostic values of m6A RNA methylation regulators in uveal melanoma
por: Tang, Jing, et al.
Publicado: (2020)

The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
por: Liu, Tao, et al.
Publicado: (2019)

Prognostic Implication of the m(6)A RNA Methylation Regulators in Rectal Cancer
por: Chen, Yajie, et al.
Publicado: (2021)

Expression of m(6)A Methylation Regulator in Osteoarthritis and Its Prognostic Markers
por: Zhang, Di, et al.
Publicado: (2022)

Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis
por: Liu, Xu-Sheng, et al.
Publicado: (2022)

Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer
por: Ma, Bin, et al.
Publicado: (2023)

Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients
por: Xu, Shaohua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g26phh5fr9tf772ovsmn7s1msa